Bausch Health Cos ROA 2010-2024 | BHC

Current and historical return on assets (ROA) values for Bausch Health Cos (BHC) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Bausch Health Cos ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2024-09-30 $-0.18B $26.54B -0.66%
2024-06-30 $-0.47B $26.50B -1.75%
2024-03-31 $-0.46B $26.91B -1.70%
2023-12-31 $-0.59B $27.35B -2.25%
2023-09-30 $-0.96B $27.06B -3.71%
2023-06-30 $-0.19B $25.50B -0.72%
2023-03-31 $-0.36B $25.45B -1.35%
2022-12-31 $-0.23B $25.69B -0.82%
2022-09-30 $0.25B $26.30B 0.90%
2022-06-30 $0.04B $28.17B 0.15%
2022-03-31 $-0.41B $29.09B -1.38%
2021-12-31 $-0.95B $29.20B -3.19%
2021-09-30 $-1.17B $29.25B -3.88%
2021-06-30 $-1.29B $30.04B -4.19%
2021-03-31 $-1.02B $30.20B -3.27%
2020-12-31 $-0.56B $31.20B -1.78%
2020-09-30 $-1.92B $31.56B -5.98%
2020-06-30 $-2.04B $31.40B -6.35%
2020-03-31 $-1.89B $31.87B -5.82%
2019-12-31 $-1.79B $33.86B -5.48%
2019-09-30 $-0.62B $31.67B -1.91%
2019-06-30 $-0.92B $32.35B -2.80%
2019-03-31 $-1.62B $32.55B -4.86%
2018-12-31 $-4.15B $32.49B -12.15%
2018-09-30 $-3.29B $33.78B -9.30%
2018-06-30 $-1.64B $34.45B -4.44%
2018-03-31 $-0.81B $35.80B -2.08%
2017-12-31 $2.40B $37.50B 5.95%
2017-09-30 $1.38B $39.97B 3.28%
2017-06-30 $-1.14B $41.73B -2.64%
2017-03-31 $-1.41B $42.33B -3.14%
2016-12-31 $-2.41B $43.53B -5.18%
2016-09-30 $-2.28B $45.76B -4.76%
2016-06-30 $-1.01B $47.66B -2.09%
2016-03-31 $-0.76B $49.02B -1.57%
2015-12-31 $-0.29B $48.97B -0.63%
2015-09-30 $0.60B $48.46B 1.48%
2015-06-30 $0.82B $48.34B 2.34%
2015-03-31 $1.00B $38.57B 3.34%
2014-12-31 $0.88B $26.31B 3.22%
2014-09-30 $0.50B $27.06B 1.81%
2014-06-30 $-0.75B $27.90B -2.66%
2014-03-31 $-0.86B $27.99B -3.31%
2013-12-31 $-0.87B $27.97B -3.71%
2013-09-30 $-1.08B $28.20B -5.17%
2013-06-30 $-0.10B $19.78B -0.57%
2013-03-31 $-0.13B $17.49B -0.82%
2012-12-31 $-0.12B $17.95B -0.78%
2012-09-30 $0.03B $14.15B 0.21%
2012-06-30 $0.06B $14.02B 0.47%
2012-03-31 $0.14B $13.62B 1.11%
2011-12-31 $0.16B $13.11B 1.31%
2011-09-30 $0.07B $11.82B 0.62%
2011-06-30 $-0.18B $11.83B -1.56%
2011-03-31 $-0.20B $11.69B -2.23%
2010-12-31 $-0.21B $10.80B -3.20%
2010-09-30 $-0.10B $11.14B -2.41%
2010-06-30 $0.14B $2.03B 7.10%
2010-03-31 $0.13B $2.01B 6.58%
2009-12-31 $0.18B $2.06B 9.15%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.597B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Acasti Pharma (GRCE) Canada $0.031B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00